The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Think the SP drop is just a further sign of how the current market operates - it seems that any half decent rise on anything is sold in to by the “floating investor” and sustained SP gains are a rarity - would be very difficult to find any fault with that RNS so you either hold LT and ignore the volatility or you go with the flow.
The “limitation to existing holders” related solely to the REX retail offer…
Thanks - no doubt ii will get their act together shortly. I emailed Gemma Cryan at SVE late last week and she advised that the liquidators had not provided any update re the AAU shares yet…
Which broker are you with as nothing received yet from ii….
SVE distribution not happened yet.
Just read a very interesting article regarding the huge amounts of water that are used by “technology”, essentially for the cooling of data servers and obviously once used for cooling the water is evaporated so gone forever. The ever increasing use of technology and AI, which is apparently even more energy dependent (ergo water also), leads to greater pressure on the scarce water resources of the planet. ONDO really does appear to be in the right place at the right time, ultimately for ALL of our benefit if it is able to reduce water wastage on a material scale via the continued roll out of Leakbot👍🏻
For anyone who was a holder of SVE and is awaiting further news, I have just had a response to my email of yesterday from Gemma Cryan of Starvest to advise that whilst she cannot give a definitive timeline, her expectation is that Moorfields will undertake the distribution of GGP shares to former SVE shareholders during January 2024…watch this space
Thanks markj…
I don’t think that the large share purchase will have had anything to do with SVE as that company had a longstanding holding in GGP and there was no expectation - or probably even ability given the “pending liquidation” status - of SVE purchasing more.
I think it was today that there should have been further news re SVE and the distribution of GGP/AAU shares to holders of the former SVE shares - not seen anything myself, has anyone else? Thanks
Hi Dan - he could sell GGP but Halifax does not allow purchase (or sale I suspect) of SVE shares.
Hi - thanks for your messages - hopefully up and running shortly…
Hi, looking to buy some SVE but my normal dealing platform (Halifax) no longer allows transactions in SVE - any pointers as to which platforms still facilitate trade in this company? Thanks
…There might be life in the old dog yet…
Closing SP of 7.4p with shares in issue of, say, 5bn gives current MC of £370m. Based on our 30% share of HAV’s current 6.5m oz AU equiv - say 2m oz AU - that would value each oz at just £185 net. With anticipated AISC at relatively modest levels and even discounting for delay in formal DTM, this seems like an unrealistic level of discounting to true value…which can only mean that once DTM is confirmed and upgraded MRE is released, we should see a sizeable re-rate…hopefully positive sentiment will return in coming weeks/months to cement those gains.
SP spread very tight for the last hour - anything 1.56 and above will be a buy, not a sell as reported on LSE, indicating ongoing appetite at this level unsurprisingly.
Kn0wles - how unlucky, they forgot to give you the discount code!?!
Think the level of debt was a key factor in the SP drop so only reasonable to expect a plan that involves debt reduction to lead to the opposite? IMO this company is well under-valued and I expect SP to continue to appreciate.
Or...that he has a huge amount of shares so that the sale of a minute element is of no real consequence irrespective of the share price...
Tygra - the RNS did confirm that it is Angus that has that many warrants outstanding as it is Angus that is referred to as the "company" within the RNS, not Aleph; that is referred to as "Aleph".
Eatstocks - whilst there may be some merit in what you are saying regarding the improved ability of the company to forecast future positions, the lack of current liquidity is emphasised by the fact that they are outside of normal payment terms with suppliers - which rather contradicts the main thrust of your argument...